Malt1 modulators and uses thereof
By designing MALT1 modulator compounds, the challenge of regulating MALT1 in immune responses and cancer has been solved, achieving therapeutic effects on autoimmune and inflammatory diseases and related cancers.
CN122167433APending Publication Date: 2026-06-09RAREFIED BIOSCIENCES INC
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- RAREFIED BIOSCIENCES INC
- Filing Date
- 2021-10-15
- Publication Date
- 2026-06-09
AI Technical Summary
Technical Problem
Current technologies have not yet effectively addressed the regulation of MALT1 in immune responses and cancer, leading to challenges in autoimmune and inflammatory diseases as well as cancers such as MALT lymphoma.
Method used
A series of compounds are provided, designed as MALT1 modulators by modulating MALT1 signaling, for the treatment of autoimmune and inflammatory diseases, disorders or conditions, and cancer.
Benefits of technology
These compounds can effectively modulate MALT1 activity, potentially treating autoimmune and inflammatory diseases and inhibiting the development of related cancers.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure SMS_3 
Figure QLYQS_1 
Figure QLYQS_2
Abstract
Provided herein are compounds, compositions, and methods useful for modulating MALT1 and for treating related diseases, disorders, and conditions.
Need to check novelty before this filing date? Find Prior Art